Rose Wilcher, MPHDirector, Research Utilization
Areas of expertise
- Gender equality
- Maternal and child health
- Reproductive health
- Capacity building
- Gender integration
- Gender analysis
- Women's empowerment
- Family planning
- Prevention of mother-to-child transmission of HIV
- Research utilization
Projects & Resources
In June 2014, the U.S. Agency for International Development awarded FHI 360 the Linkages across the Continuum of HIV Services for Key Populations Affected by HIV Project (LINKAGES), a five-year cooperative agreement funded by the U.S. President's Emergency Plan for AIDS Relief.
FHI 360 developed and introduced innovative HIV prevention technologies — including microbicides and antiretrovirals — and worked with local partners to address the need for HIV prevention options, particularly for women.
Linkages Across the Continuum of HIV Services for Key Populations Affected by HIV (LINKAGES) Gender Strategy
This resource explains the rationale and the process for implementing the gender strategy for the Linkages Across the Continuum of HIV Services for Key Populations Affected by HIV (LINKAGES) project.
This toolkit provides practical guidance to governments, funders, civil society organizations and other implementing partners on conducting a gender analysis and using findings to inform HIV prevention, care and treatment programs with key populations.
These practical and adaptable tools are intended to support strategic planning for research utilization during study design, stakeholder analysis and systematic tracking of interventions during study implementation.
Published Research/** * @file * Unformatted override for published research. * Using the same markup as "project" because it's the same */ ?>
Optimizing HIV prevention for women: A review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction
Doggett EG, Lanham M, Wilcher R, Gafos M, Karim QA, Heise L.
J Int AIDS Soc 2015 Dec; 18 (1): 20536. [Journal Impact Factor: 5.090]
Gender-related norms and inequalities that place women and girls at risk of acquiring HIV are also likely to affect their ability to use microbicides. Published vaginal microbicide studies were reviewed to identify gender-related factors that are likely to affect microbicide acceptability, access and adherence. This paper makes recommendations on product design, trial implementation, positioning, marketing and delivery of microbicides in a way that takes into account the gender-related norms and inequalities identified in the review.